JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 5. Photomicrographs of neuroblastoma cells (NBP2) in culture after treatment with RO20-1724, an inhibitor of cyclic nucleotide phosphodiesterase, and a polar carotenoid originally referred to as beta-carotene [52]. Control a) 4 days after plating (50,000 cells/60-mm dish) showing mostly round cells; polar carotenoid (20 µg/mL-treated cells; b) 4 days after treatment showing no significant change in morphology; RO20-1724 (200 µg/mL)-treated cells; c) 4 days after treatment revealing increased number of cells with neurites; cells treated with RO20-1724 plus polar carotenoid d) for a period of 4 days showing more differentiated cells than those produced by RO20-1724 treatment alone; cells treated with RO20-1724 plus polar carotenoid for a period of 8 days e) and f) 11 days showing extensive network of neurites [53] x200.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS